Chemical & Healthcare Archives - Page 7 of 13

AUSTRALASIA

18th Aug 2017

Australia Update: Patent Term Extensions Not Available on the Basis of Swiss-style Claims

AbbVie Biotechnology Ltd v Commissioner of Patents AATA 682 has been overturned. Today, the Full Federal Court set aside a decision of the Administrative Appeals Tribunal thereby making...

AbbVie Biotechnology Ltd v Commissioner of Patents AATA 682 has been overturned. Today, the Full Federal Court set...

AUSTRALASIA

3rd Aug 2017

Menarini Industrie Farmaceutiche Riunite S.r.l. [2017] NZIPOTM 5 (8 February 2017)

Menarini Industrie Farmaceutiche Riunite S.r.l (“Menarini”) applied to register the mark KETUM in relation to an“anti-inflammatory drug used to ease joint and muscle pain” in class 5.

Menarini Industrie Farmaceutiche Riunite S.r.l (“Menarini”) applied to register the mark KETUM in relation to an“anti-inflammatory drug used to...

AUSTRALASIA

31st May 2017

Update on Swiss-type patent claims in Australia

As discussed in our previous article, ‘Swiss-type’ format is one of several claim types that can be used in Australia for obtaining protection related to therapeutics. The general structure...

As discussed in our previous article, ‘Swiss-type’ format is one of several claim types that can be used in...

GREATER CHINA

18th May 2017

Chinese Food and Drug Administration (CFDA) Proposes New Patent Linkage and Data Protection Regime

On 12 May , 2017 the CFDA published its intention to work on a new patent linkage and data protection system for China as part of a reform...

On 12 May , 2017 the CFDA published its intention to work on a new patent linkage and data...

AUSTRALASIA

8th May 2017

Bayer awarded indemnity costs against Generic Health in Yasmin patent litigation

Earlier this year Jagot J of the Federal Court of Australia ordered Generic Health to pay Bayer $25,437,966 in damages plus interest to compensate for lost revenue caused by generic product sales...

Earlier this year Jagot J of the Federal Court of Australia ordered Generic Health to pay Bayer $25,437,966 in...

AUSTRALASIA

18th Apr 2017

Full Federal Court confirms that applying for PBS listing may not be an infringement

On appeal from Apotex Pty Ltd v Warner-Lambert LLC (No 3) FCA 94, which we recently reported on here, the Full Federal Court has confirmed in Warner-Lambert Company...

On appeal from Apotex Pty Ltd v Warner-Lambert LLC (No 3) FCA 94, which we recently reported on...

SOUTHEAST ASIA

13th Apr 2017

Singapore High Court clarifies determining facts for inventorship and ownership

On 14 March 2017, the Singapore High Court issued an amended decision on National University Hospital Singapore Pte Ltd v. Cicada Cube Pte Ltd SGHC 53.

On 14 March 2017, the Singapore High Court issued an amended decision on National University Hospital Singapore Pte Ltd...

AUSTRALASIA

2nd Mar 2017

Australia Update: Counterfeit BIO-OIL and additional and exemplary damages in IP disputes

Additional damages for trade mark and copyright infringement and exemplary damages for passing off were recently considered in the Federal Court case Geneva Laboratories Limited and anor v Prestige...

Additional damages for trade mark and copyright infringement and exemplary damages for passing off were recently considered in the...

AUSTRALASIA

16th Feb 2017

Australia Update: When is applying for listing on the Pharmaceutical Benefits Scheme not an infringement?

In the most recent judgement in the Australian Lyrica® litigation Nicholas J has delivered an interesting decision regarding whether applying for Pharmaceutical Benefits Scheme (PBS) listing constitutes infringement of...

In the most recent judgement in the Australian Lyrica® litigation Nicholas J has delivered an interesting decision regarding whether...

AUSTRALASIA

22nd Dec 2016

Australian Government releases Productivity Commission’s final report on IP arrangements

In December 2016 the Australian Government released the Productivity Commission's final Report on Intellectual Property (IP) arrangements in Australia.

AUSTRALASIA

9th Dec 2016

A comparative study of strategies for patenting human therapeutics in the Asia Pacific Region: IP In Depth

In the last century, innovations in the life sciences have allowed for treatment and prevention of numerous diseases and disorders, enabling higher life expectancy and improved quality of life....

In the last century, innovations in the life sciences have allowed for treatment and prevention of numerous diseases and...

AUSTRALASIA

9th Dec 2016

Recent Patent Office decision provides further clarity in patentability of nucleic acids in Australia

As has been widely reported, the patentability or otherwise of isolated nucleic acids has been a rapidly evolving question through the Australian Courts and Patent Office in recent years. A...

As has been widely reported, the patentability or otherwise of isolated nucleic acids has been a rapidly evolving question...